Position in ALKS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,539,145
+$381,848 QoQ
Shares Held
29,373
-10.3% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#194
of 423 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ProShare Advisors LLC holds $31,211,469 across 27 Drug Manufacturers - Specialty & Generic names. ALKS ranks #5 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
109,096 | $7,839,638 | |
| 2 | PRGO |
PERRIGO Co plc
|
632,256 | $6,569,139 | |
| 3 | VTRS |
Viatris Inc
|
236,959 | $3,762,908 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
3,067 | $1,661,792 | |
| 5 | ALKS |
Alkermes plc.
This page
|
29,373 | $1,539,145 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
37,512 | $1,300,541 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
11,126 | $1,234,318 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
7,264 | $1,224,274 |
All Filings in ALKS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,539,145 | 29,373 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,157,297 | 32,729 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $1,087,694 | 38,874 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,094,910 | 36,497 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,213,693 | 42,422 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,495,343 | 45,286 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,616,628 | 56,211 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,229,796 | 43,937 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $868,829 | 36,051 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,222,806 | 45,172 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,160,142 | 41,822 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $908,812 | 32,446 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,011,897 | 32,329 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $862,275 | 30,588 | Shares | Sole | 2023-05-26 | |
| 2022-12-31 | $968,482 | 37,064 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $768,330 | 34,408 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $1,004,637 | 33,724 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $1,329,681 | 50,539 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,439,235 | 61,876 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,814,625 | 58,840 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,869,576 | 76,247 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $467,504 | 25,027 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $547,029 | 27,420 | Shares | Sole | 2021-02-09 | |
| 2020-06-30 | $542,082 | 27,928 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $354,256 | 24,567 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||